James Marvin Veal

Title: James Marvin Veal: Innovator in Protein Kinase Inhibitors

Introduction

James Marvin Veal is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of protein kinase inhibitors. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

James Marvin Veal holds a patent for "Fused pyrazole derivatives being protein kinase inhibitors." This patent includes compounds of Formula (I), which are described as salts, solvates, or physiologically functional derivatives. The compounds feature substituent groups where Z can be CH or N, making them valuable in the development of therapeutic agents targeting protein kinases. He has 1 patent to his name, reflecting his focused contributions to this specialized area.

Career Highlights

Veal is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His role at Glaxo has allowed him to work on cutting-edge research and development projects, contributing to the advancement of new treatments. His work is characterized by a commitment to innovation and a deep understanding of complex biochemical processes.

Collaborations

Throughout his career, James Marvin Veal has collaborated with esteemed colleagues, including Michael John Alberti and Ian Robert Baldwin. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in their field.

Conclusion

James Marvin Veal's contributions to the field of protein kinase inhibitors exemplify the impact of dedicated inventors in the pharmaceutical industry. His innovative work continues to influence the development of new therapeutic agents, showcasing the importance of research and collaboration in advancing medical science.